Adage Capital Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-500,000
| Closed | -$7.89M | – | 949 |
|
|
2023
Q3 | $7.89M | Buy |
500,000
+100,000
| +25% | +$1.58M | 0.02% | 611 |
|
|
2023
Q2 | $7.78M | Hold |
400,000
| – | – | 0.02% | 608 |
|
|
2023
Q1 | $11.3M | Hold |
400,000
| – | – | 0.03% | 590 |
|
|
2022
Q4 | $11.7M | Buy |
400,000
+150,000
| +60% | +$4.38M | 0.03% | 596 |
|
|
2022
Q3 | $6.61M | Hold |
250,000
| – | – | 0.02% | 743 |
|
|
2022
Q2 | $11.1M | Buy |
+250,000
| New | +$11.1M | 0.03% | 643 |
|
|
2018
Q3 | – | Sell |
-50,000
| Closed | -$3.78M | – | 769 |
|
|
2018
Q2 | $3.78M | Buy |
+50,000
| New | +$3.78M | 0.01% | 669 |
|
|
2016
Q3 | – | Sell |
-20,000
| Closed | -$776K | – | 736 |
|
|
2016
Q2 | $776K | Buy |
+20,000
| New | +$776K | ﹤0.01% | 665 |
|